Show simple item record

dc.contributor.authorPrity, Beth
dc.contributor.authorTickle, Anna C.
dc.date.accessioned2022-01-05T14:37:42Z
dc.date.available2022-01-05T14:37:42Z
dc.date.issued2021
dc.identifier.citationShepherd, K., Pritty, B., Tickle, A. C. & Moghaddam, N. (2021). "I don't want to take buprenorphine for the rest of my life": Acceptance and commitment therapy for a client struggling to reduce low-dose buprenorphine (a hermeneutic single-case efficacy design). International Journal of Mental Health and Addiction, DOI: 10.1007/s11469-021-00729-2en_US
dc.identifier.other10.1007/s11469-021-00729-2
dc.identifier.urihttp://hdl.handle.net/20.500.12904/15052
dc.description.abstractThe misuse of substances is often maintained by both physical and psychological factors. Opioid-substitution medications manage physical aspects of addiction; however, difficulties with emotional regulation and avoidance perpetuate continued substance misuse. In the UK, individuals who misuse substances are often excluded from mental health services, meaning these underlying difficulties are not addressed. Acceptance and Commitment Therapy (ACT) seeks to reduce emotional avoidance. A hermeneutic single-case efficacy design was used to evaluate the effects of ACT within drugs and alcohol service. Quantitative and qualitative data was critically analysed to understand factors involved in identified changes. Analysis recognised the client progressed towards two of three of their goals, related to motivation and anxiety. Their psychological flexibility also increased. ACT processes played a key role in this; however, the therapeutic relationship and psychopharmacological factors were also noted. Study limitations and clinical and research implications are discussed.
dc.description.urihttps://link.springer.com/article/10.1007%2Fs11469-021-00729-2en_US
dc.language.isoenen_US
dc.subjectDrug therapyen_US
dc.subjectSubstance-related disordersen_US
dc.subjectPsychotherapyen_US
dc.subjectAddictive behaviouren_US
dc.subjectCognitive therapyen_US
dc.title"I don't want to take buprenorphine for the rest of my life": Acceptance and commitment therapy for a client struggling to reduce low-dose buprenorphine (a hermeneutic single-case efficacy design)en_US
dc.typeArticleen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
rioxxterms.versionNAen_US
rioxxterms.typeJournal Article/Reviewen_US
refterms.panelUnspecifieden_US
refterms.dateFirstOnline2021-12-20
html.description.abstractThe misuse of substances is often maintained by both physical and psychological factors. Opioid-substitution medications manage physical aspects of addiction; however, difficulties with emotional regulation and avoidance perpetuate continued substance misuse. In the UK, individuals who misuse substances are often excluded from mental health services, meaning these underlying difficulties are not addressed. Acceptance and Commitment Therapy (ACT) seeks to reduce emotional avoidance. A hermeneutic single-case efficacy design was used to evaluate the effects of ACT within drugs and alcohol service. Quantitative and qualitative data was critically analysed to understand factors involved in identified changes. Analysis recognised the client progressed towards two of three of their goals, related to motivation and anxiety. Their psychological flexibility also increased. ACT processes played a key role in this; however, the therapeutic relationship and psychopharmacological factors were also noted. Study limitations and clinical and research implications are discussed.en_US
rioxxterms.funder.project94a427429a5bcfef7dd04c33360d80cden_US


This item appears in the following Collection(s)

Show simple item record